Sfoglia per RIVISTA
BLOOD
Collezione ASL Asti

  

Items : 19

Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: a case-control study. in Blood / Blood. 2020 Jan 30;135(5):381-386. doi: 10.1182/blood.2019002614.

2020
ASL Asti
AO Cuneo
AOU Città della Salute di Torino
ASL Vercelli
AOU Novara

Di Veroli A; Barbui T; Vannucchi AM; Rambaldi A; Griesshammer M; Alvarez-Larran A; Marchetti M; Isfort S; Recasens V; McMullin MF; Tieghi A; Carli G; Cacciola R; Benevolo G; Fox ML; Beggiato E; Angona A; Lunghi F; Wille K; Perez-Encinas M; Gomez M; Erez D; Rapezzi D; Elli EM; Palova M; Casetti IC; Stephenson C; Guglielmelli P; Scaffidi L; et alii...

Chronic lymphocytic leukemia management in Italy during the COVID-19 pandemic: a Campus CLL report. in Blood / Blood. 2020 Aug 6;136(6):763-766. doi: 10.1182/blood.2020006854.

2020
ASL Asti
AOU Città della Salute di Torino
ASL Vercelli

Trentin L; Mauro FR; Gattei V; Ibatici A; Orsucci L; Rigolin GM; Pietrasanta D; Re F; De Paoli L; Marchetti M; Quaglia FM; Varettoni M; Reda G; Scarfò L; Cuneo A; Laurenti L; Marasca R; Foà R;

Retrospective Real-Life Comparison of Obinutuzumab Plus Chlorambucil Versus Ibrutinib in Previously Untreated and Unfit Patients with Chronic Lymphocytic Leukemia without TP53 Disruptions. Interim Results from the Italian CLL Campus in Blood

2020
ASL Asti
AOU Città della Salute di Torino

Visentin A; Mauro FR; Pietrasanta D; Fresa A; Vitale C; Ciolli S; Cassin R; Cibien F; Sportoletti P; Gentile M; Rigolin GM; Quaglia FM; Murru R; Gozzetti A; Molica S; Marchetti M; Scarfo L; Reda G; Coscia M; Laurenti L; Pizzolo G; Semenzato G; Foà R; Cuneo A; Trentin L;

Worldwide Examination of Patients with CLL Hospitalized for COVID-19 in Blood

2020
ASL Asti
AOU Città della Salute di Torino

Roeker LE; Scarfo L; Chatzikonstantinou T; Abrisqueta P; Eyre TA; Cordoba R; Muntañola Prat A; Villacampa G; Leslie LA; Koropsak M; Quaresmini G; Allan JN; Furman RR; Bhavsar EB; Pagel JM; Hernandez-Rivas JA; Patel K; Motta M; Bailey N; Miras F; Lamanna N; Alonso R; Osorio-Prendes S; Vitale C; Kamdar M; Baltasar P; Österborg A; Hanson L; Baile M; et alii...

Selecting ß-Thalassemia Patients for Gene Therapy: A Decision-Making Algorithm in Blood

2019
ASL Asti

Baronciani D; Casale M; De Franceschi L; Graziadei G; Longo F; Origa R; Pinto VM; Rigano P; Marchetti M; Gigante A; Angelucci E; Cappellini MD; Iolascon A; Piga A; Forni GL;

Pre-Existing and Treatment-Emergent Autoimmune Cytopenias in Patients with Chronic Lymphocytic Leukemia Treated with Targeted Drugs in Blood

2019
ASL Asti
AOU Città della Salute di Torino

Vitale C; Salvetti C; Griggio V; Scamuffa MC; Zamprogna G; Visentin A; Cassin R; Laurenti L; Murru R; Rivela P; Marchetti M; Gentile M; Pennese E; Reda G; Trentin L; Tedeschi A; Mauro FR; Foà R; Boccadoro M; Coscia M;

Frequency of Thrombosis Is Higher in MPN Patients Who Develop Second Cancer Than in Controls in Blood

2019
ASL Asti
AOU Città della Salute di Torino

De Stefano V; Ghirardi A; Masciulli A; Carobbio A; Palandri F; Vianelli N; Rossi E; Betti S; Di Veroli A; Iurlo A; Cattaneo D; Finazzi G; Bonifacio M; Scaffidi L; Patriarca A; Rumi E; Casetti IC; Stephenson C; Guglielmelli P; Elli EM; Palova M; Rapezzi D; Erez D; Gomez M; Wille K; Pérez-Encinas M; Lunghi F; Angona A; Fox ML; et alii...

Short course of bortezomib in anemic patients with relapsed cold agglutinin disease: a phase 2 prospective GIMEMA study. in Blood / Blood. 2018 Aug 2;132(5):547-550. doi: 10.1182/blood-2018-03-835413. Epub 2018 Jun 13.

2018
ASL Asti
ASL Vercelli

Fazi P; Marchetti M; Salvi F; Mauro FR; Lucchini E; Farina M; D'Adda M; Binda F; Fattizzo B; Paoloni F; Gramegna D; Rossi G; Zaja F; Barcellini W;

Myelodysplastic syndromes with hypocellular marrow: Clinical characteristics and evaluation of outcome in Blood

2018
ASL Asti
ASL Torino 5
AO Cuneo
AOU Città della Salute di Torino

Santini V; Gioia DM; Masiera E; Poloni A; Ferrero D; Fragasso A; Finelli C; Salvi F; Gaidano G; Oliva EN; Catarini M; Cametti G; Bonferroni M; Danise P; Tassara R; Allione B; Cilloni D; Castelli A; Centurioni R; Ciravegna G; Visani G; Musto P; Balleari E; Boveri E; Ponzoni M; Gianelli U; Della Porta MG;

Pretreatment health-related quality of life profile according to the eortc QLQ-C30 in patients with myelodysplastic syndromes (MDS): Analysis on 443 lower-risk MDS patients in Blood

2018
ASL Asti

Efficace F; Ricco A; Breccia M; Frairia C; Fianchi L; Sanpaolo G; Crugnola M; Invernizzi R; Luppi M; Stauder R; Petranovic D; Platzbecker U; Caocci G; Fedele M; Palumbo GA; Cottone F; Patriarca A; Niscola P; Karakantza M; Vignetti M; Canicattì M; Zhang H; Di Renzo N; Cuneo A; Kyriakou C; Voso MT; Fozza C; Santini V; Caers J; et alii...

Impact of transfusion dependency on health-related quality of life outcomes in newly diagnosed patients with myelodysplastic syndromes (MDS). Analysis on 669 patients by disease risk in Blood

2017
ASL Asti

Niscola P; Efficace F; Borin LM; Bergamaschi M; Invernizzi R; Cottone F; Canicattì M; Okumura I; Allione B; Vallisa D; Voso MT; Palumbo GA; Breccia M; Gaidano G; Ricco A; Caocci G; Mandelli F; Vignetti M; Cascavilla N; Caers J; Petranovic D; Luppi M; Platzbecker U; Stauder R; Zhang H; Angela Di Tucci A;

Efficacy and safety of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia: Results of the GIMEMA-ERIC LLC1315 study in Blood

2017
ASL Asti

Ghia P; Foa R; Follows GA; De La Serna J; Vignetti M; Gaidano G; Ilariucci F; Meneghini V; Chiarenza A; González M; Re F; Marchetti M; Marasca R; Pizzuti M; Visco C; Ciolli S; Orlandi EM; Rivas-Delgado A; Farina L; Musuraca G; Coscia M; Perez AM; Trentin L; Gentile M; Montillo M; Molica S; Mauro FR; Laurenti L; Galieni P; et alii...

Short course of bortezomib in anemic patients with refractory or relapsed cold agglutinin disease. a phase II prospective study by the gimema group in Blood

2017
ASL Asti

Rossi G; Paoloni F; Fattizzo B; Binda F; D'Adda M; Farina M; Carbone C; Zaja F; Lucchini E; Mauro FR; Salvi F; Marchetti M; Fazi P; Barcellini W;

Is idelalisib cost-effective for refractory/relapsed chronic lymphocytic leukemia? A decision analysis in the second-line setting in Blood

2015
ASL Asti

Marchetti M; Cuneo A; Mauro FR; Montillo M; Martelli E; Pedone MP;

The hypoxia-inducible factor-1alpha is constitutively upregulated in TP53 disrupted CLL cells: A potential target to overcome fludarabine resistance in Blood

2015
AO Ordine Mauriziano
ASL Asti

Griggio V; Vitale C; Riganti C; Kopecka J; Dal Bo M; Rossi D; Pozzato G; Laurenti L; Zallio F; Marchetti M; Ruggeri M; Omedè P; Del Poeta G; Gattei V; Gaidano G; Boccadoro M; Massaia M; Coscia M;

Iron supplementation adjunct to erythropoiesis stimulating agents is cost saving for chemotherapy-related anemia in the era of biosimilars in Blood

2014
ASL Asti

Marchetti M; Barosi G; Pedrazzoli P;

Should I transplant this patient with paroxysmal nocturnal hemoglobinuria? A cost-effectiveness analysis of eculizumab versus allogeneic stem cell transplant in Blood

2014
ASL Asti

Marchetti M; Barosi G;

Cost-effectiveness of interim PET response adapted therapy in ABVD-treated, advanced-stage Hodgkin lymphoma in Blood

2011
ASL Asti

Gallamini A; Marchetti M; Borra A; Sorasio R; Fiore F;

Comparison among citology, histology, and flow cytometry in evaluating blast values in myelodysplatic syndromes (MDS). Survey from the Italian “Piemonte MDS registry” in Blood

2010
ASL Asti
ASL Torino 4
AO Cuneo

Levis A; Gioia DM; Godio L; Girotto M; Allione B; Bertassello C; Bonferroni M; Ciriello MM; Cametti G; Ciravegna G; Ferranti A; Lunghi M; Ferrero D; Freilone R; Gatto S; Salvi F; Savio M; Scaravaglio P; Stacchini A; Tonso A; Boccadoro M; Gaidano G; Gallamini A; Vitolo U; Saglio G;